David Moatazedi

See Remarks

David Moatazedi (See Remarks) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Evolus, Inc. (EOLS). The largest single filing was $950K of EOLS (105,108 sh × $9.04, as filed), executed Sep 2.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 2 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.5M

shares × price, as filed

Last traded

Sep 2

Filed Sep 4

Median ADV $8.3M across their filed names

Open performance→

Volume by month

Buys $0 Sells $4.4M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names

EOLS

Evolus, Inc. EOLS · 0 buys · 6 sells 6 filings

Recent filings

EOLSSALE Evolus, Inc. View filing → $950K
105,108 sh × $9.04
Exec Sep 2
Filed Sep 4 · 7:04 PM ET EOLSSALE Evolus, Inc. View filing → $571K
116,720 sh × $4.89
Exec Mar 17
Filed Mar 18 · 5:30 PM ET EOLSSALE Evolus, Inc. View filing → $1.3M
127,905 sh across 2 lots
Exec Jun 13 2025
Filed Jun 16 2025 · 5:30 PM ET EOLSSALE Evolus, Inc. View filing → $156K
15,787 sh × $9.87
Exec May 12 2025
Filed May 14 2025 · 5:30 PM ET EOLSSALE Evolus, Inc. View filing → $1.4M
103,376 sh × $13.26
Exec Mar 18 2025
Filed Mar 20 2025 · 5:30 PM ET EOLSSALE Evolus, Inc. View filing → $114K
10,502 sh × $10.85
Exec Dec 23 2024
Filed Dec 26 2024 · 5:30 PM ET